XML 59 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
Licensed rights and other intangible assets - Summary of Information about License Rights and Other Intangible Assets, Net (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross Carrying Amount $ 48,125 $ 47,854
Finite-Lived Intangible Assets, Accumulated Amortization 10,570 7,868
Finite-Lived Intangible Assets, Net 37,555 39,986
License Rights and Intangible Assets, Net, Gross Carrying Amount (Excluding Goodwill) 48,446 48,186
License rights and other intangible assets, net 37,876 40,318
License rights [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross Carrying Amount 40,000 40,000
Finite-Lived Intangible Assets, Accumulated Amortization 9,086 6,826
Finite-Lived Intangible Assets, Net 30,914 33,174
Hormone therapy drug patents [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross Carrying Amount 6,189 5,834
Finite-Lived Intangible Assets, Accumulated Amortization 1,484 1,042
Finite-Lived Intangible Assets, Net 4,705 4,792
Hormone therapy drug candidate patents - applied and pending [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross Carrying Amount 1,936 2,020
Finite-Lived Intangible Assets, Net 1,936 2,020
Trademarks/trade name rights [Member]    
Finite-Lived Intangible Assets [Line Items]    
Indefinite-Lived Intangible Assets, Gross Carrying Amount and Net $ 321 $ 332